| JYHZ2400105 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | License Renew | 2024-05-07 | | | | | view |
| JYHZ2400104 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | License Renew | 2024-05-07 | | | | | view |
| JYHZ1900133 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | License Renew | 2019-05-29 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-12-05 | view |
| JYHZ1900132 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | License Renew | 2019-05-29 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-12-12 | view |
| JYHB2101026 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2021-04-10 | | | | | view |
| JYHB2101025 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2021-04-10 | | | | | view |
| JYHB2001898 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-09-29 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Filed | 2020-10-16 | view |
| JYHB2001897 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-09-29 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Filed | 2020-10-16 | view |
| JYHB2001531 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-08-24 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-11-12 | view |
| JYHB2001530 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-08-24 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-11-12 | view |
| JYHB2000277 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-03-25 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-05-11 | view |
| JYHB2000276 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-03-25 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-05-11 | view |
| JYHB1901070 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2019-09-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-11-06 | view |
| JYHB1901069 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2019-09-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-11-06 | view |
| JYHB1601752 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2017-01-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-06-07 | view |
| JYHB1601750 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2017-01-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-06-07 | view |
| JYHB1501184 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2015-08-24 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-29 | view |
| JYHB1501183 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2015-08-24 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-29 | view |
| JYHB0901070 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2009-12-08 | Pfizer Inc. | Pfizer Inc | Certificate Issued | 2010-06-24 | view |
| JYHB0901069 | 阿昔替尼片 | axitinib | Tablet | Chemical Drugs | Supplementary Application | 2009-12-08 | Pfizer Inc. | Pfizer Inc | Certificate Issued | 2010-06-24 | view |
